Lung Cancer Incidence Trends by Gender, Race and Histology in the United States, 1973–2010

Abstract

BackgroundLung cancer (LC) incidence in the United States (US) continues to decrease but with significant differences by histology, gender and race. Whereas squamous, large and small cell carcinoma rates have been decreasing since the mid-80s, adenocarcinoma rates remain stable in males and continue to increase in females, with large racial disparities. We analyzed LC incidence trends by histology in the US with an emphasis on gender and racial differences.MethodsLC incidence rates from 1973–2010 were obtained from the SEER cancer registry. Age-adjusted incidence trends of five major histological types by gender and race were evaluated using joinpoint regression. Trends of LC histology and stage distributions from 2005–2010 were analyzed.ResultsUS LC incidence varies by histology. Squamous, large and small cell carcinoma rates continue to decrease for all gender/race combinations, whereas adenocarcinoma rates remain relatively constant in males and increasing in females. An apparent recent increase in the incidence of squamous cell carcinoma and adenocarcinoma since 2005 can be explained by a concomitant decrease in the number of cases classified as other non-small cell carcinoma. Black males continue to be disproportionally affected by squamous LCs, and blacks continue to be diagnosed with more advanced cancers than whites.ConclusionsLC incidence by histology continues to change over time. Additional variations are expected as screening becomes disseminated. It is important to continue to monitor LC rates to evaluate the impact of screening on current trends, assess the continuing benefits of tobacco control, and focus efforts on reducing racial disparities.

Comparison of Smoking History Patterns Among African American and White Cohorts in the United States Born 1890 to 1990

“…Rates for males are considerably higher for blacks than for whites, and for females rates for blacks are slightly lower than whites. 8,9 Reasons for these disparities are not well understood, but are likely to be due to either different intensities or durations of cigarette exposure, especially at ages with high absolute risk of lung cancer. Levels of carcinogen exposure may not be conveyed by an interview response because of differences in the way individuals smoke, the chosen brand or the individuals metabolic function for removing toxins.…”

Lobectomy for non-small cell lung carcinoma: a nationwide study of short- and long-term survival

“…In Europe and North America, non-small cell lung carcinoma (NSCLC) accounts for around 80% of LC [3], where surgical resection is the only well-defined and well-studied curative treatment [4]. Pulmonary resection is indicated for patients with localized or regional disease, which currently applies to almost one-third of all patients diagnosed with NSCLC in Iceland [2].…”

Platinum-Based Adjuvant Chemotherapy for Stage II and Stage III Squamous Cell Carcinoma of the Lung

“…1,2) The prognoses of SCC and pulmonary adenocarcinoma differ according to lung cancer progression after complete resection. In stage I lung cancer, disease-free survival (DFS) and overall survival (OS) of patients with SCC are poorer than those of patients with pulmonary adenocarcinoma because adenocarcinoma in situ or minimally invasive adenocarcinoma confers good prognoses after curative resection.…”